FDA Roundup: April 30, 2024
FDA Roundup: April 30, 2024
FDA Roundup: April 30, 2024
Oncologists tackle angiosarcoma of the breast with an intensive regimen of daily radiation.
Hypertension can be a silent killer. Learn what doctors wish patients knew about which changes to make to lower BP and why they matter.
A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced.
With tens of thousands of Americans already affected by enrollment scams that leave some without doctors or treatments, Oregon Sen. Ron Wyden wants increased enforcement…
Optum Rx is rolling out a new pharmacy model that seeks to make drug costs more predictable and transparent for clients. | Optum Rx is…
The copycats are possible because of drug shortages.
A new coalition called Tech Against Scams is bringing companies together to fight online fraud.
In recent years, the phenomenon of physiological synchrony has captivated behavioral researchers seeking to understand how human brains and bodies align during social interactions.
The legalization of cannabis and the popularity of its edible versions is having an unexpected effect: More seniors landing in emergency departments with overdoses.
The Vatican has always been an institution shrouded in mystery. Recently, it has made headlines by deciding to issue new guidelines on aliens and how…